Jerome Zeldis
Overview
Jerome Zeldis received an average of $3M in total compensation, including $397K in salary, at NexImmune between 2021 and 2022. Jerome Zeldis also received an average of $713K at Sorrento Therapeutics between 2016 and 2017.
Source: SEC filings on April 4, 2023, July 19, 2018, and June 26, 2017.
Related executives
We found 17 more executives who work or worked at NexImmune and Sorrento Therapeutics.
Kristi Jones
NexImmune
Chief Executive Officer
John Trainer
NexImmune
Chief Financial Officer
Mathias Oelke
NexImmune
Chief Scientific Officer
Scott Carmer
NexImmune
Chief Executive Officer
Henry Ji
Sorrento Therapeutics
Chief Executive Officer
Najjam Asghar
Sorrento Therapeutics
Chief Financial Officer
Jiong Shao
Sorrento Therapeutics
Chief Financial Officer
George Ng
Sorrento Therapeutics